Efficacy and Safety of Low Dose Prasugrel in Japanese Acute Coronary Syndrome Patients: A Single-center Prospective Clinical Trial
Not Applicable
Completed
- Conditions
- Acute Coronary Syndrome
- Registration Number
- JPRN-UMIN000019164
- Lead Sponsor
- Kurashiki Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
(1) bleeding patients (hemophilia, cerebral bleeding, gastrointestinal bleeding, urinary tract bleeding, hemoptysis, or vitreous hemorrhage) (2) hypersensitive patients for prasugrel in past times (Relative exclusion criteria) (1) patients with cerebral bleeding or critical bleeding (BARC classification 3 or greater) (2) patients with past history of cerebral infarction or transient ischemic attack (3) patients with anticoagulant therapy or scheduled for anticoagulant therapy (4) patients with thienopyridine therapy already
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method